Dr. Matias Emanuel Valsecchi, MD

Dr. Valsecchi practices at St. Mary's Regional Hospital in Grand Junction, Colorado, part of Intermountain Health.

Dr. Valsecchi's NPI, 1235338328, was assigned on July 17, 2007. Dr. Valsecchi holds West Virginia license 25266.

Dr. Valsecchi's primary practice is St. Mary's Regional Hospital, at 2635 N 7th St, Grand Junction, CO 81501 in Mesa County. The practice phone is (970) 298-2260. Dr. Valsecchi also practices at St. Mary's Medical Center, 2900 1st Ave, Huntington, WV 25702.

Dr. Valsecchi's primary practice is St. Mary's Regional Hospital in Grand Junction, Colorado, part of Intermountain Health. Dr. Valsecchi is also affiliated with St. Mary's Medical Center. The medical group on file is HIMG (Huntington Internal Medicine Group). Dmand AI also links Dr. Valsecchi to 2 more hospitals, 2 group practices and clinics, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Valsecchi practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Valsecchi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Valsecchi's licenses on file in 2 states: West Virginia and Pennsylvania.

CMS data shows 1,781 Medicare services from Dr. Valsecchi across 11 procedure codes in 2024, for 459 Medicare patients. Medicare paid $118,924 for them.

CMS counts 459 Medicare patients who saw Dr. Valsecchi in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Valsecchi's median patient age at 73, with 53% women.

In 2024, Dr. Valsecchi wrote 1,875 Medicare Part D claims for 339 patients. 73% of them were for generic drugs. CMS names the drug for 1,674 of them, across 41 drugs with 11 or more claims each, at $3,396,569 in total drug cost. In 2023, CMS named 1,423 claims across 35 drugs.

Dr. Valsecchi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Valsecchi, published from 2011 to 2024. 2011 was the busiest year, with 5. The most frequent topics are Antineoplastic Agents, Melanoma and Skin Neoplasms. Dr. Valsecchi has published most often in Rev Recent Clin Trials. Dr. Valsecchi's most frequent co-authors are Takami Sato, MD, Damian Silbermins, MD and Marlana Maria Orloff, MD.

CMS Open Payments shows 1,381 general payments to Dr. Valsecchi from 89 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Bristol-Myers Squibb Company paid the most, $6,145.